BR112014007513A2 - composições para remoção rf - Google Patents

composições para remoção rf

Info

Publication number
BR112014007513A2
BR112014007513A2 BR112014007513A BR112014007513A BR112014007513A2 BR 112014007513 A2 BR112014007513 A2 BR 112014007513A2 BR 112014007513 A BR112014007513 A BR 112014007513A BR 112014007513 A BR112014007513 A BR 112014007513A BR 112014007513 A2 BR112014007513 A2 BR 112014007513A2
Authority
BR
Brazil
Prior art keywords
removal compositions
embolic agent
compositions
nanoparticles
removal
Prior art date
Application number
BR112014007513A
Other languages
English (en)
Inventor
L Carroll David
L Berry Joel
H Rolland Pierre
Original Assignee
Univ Wake Forest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest filed Critical Univ Wake Forest
Publication of BR112014007513A2 publication Critical patent/BR112014007513A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

resumo composições para remoção rf num aspecto, as composições de compostos são aqui descritos. em algumas formas de realização, uma composição de compósito compreende um agente embólico e uma pluralidade de nanopartículas dispersas no agente embólico, em que uma porção das nanopartículas é dispersa individualmente no agente embólico.
BR112014007513A 2011-09-28 2012-09-28 composições para remoção rf BR112014007513A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161540252P 2011-09-28 2011-09-28
PCT/US2012/057965 WO2013049600A1 (en) 2011-09-28 2012-09-28 Compositions for rf ablation

Publications (1)

Publication Number Publication Date
BR112014007513A2 true BR112014007513A2 (pt) 2017-12-12

Family

ID=47074889

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014007513A BR112014007513A2 (pt) 2011-09-28 2012-09-28 composições para remoção rf

Country Status (6)

Country Link
US (1) US20140228840A1 (pt)
EP (1) EP2760472A1 (pt)
JP (1) JP2014528000A (pt)
CN (1) CN104066450A (pt)
BR (1) BR112014007513A2 (pt)
WO (1) WO2013049600A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11890045B2 (en) * 2017-03-03 2024-02-06 Regents Of The University Of Minnesota Materials and treatments using piezoelectric embolic materials
WO2018234896A1 (en) * 2017-06-20 2018-12-27 Abdolahad Mohammad REAL-TIME AND MARKER-FREE ANALYZER FOR IN VITRO AND IN VIVO DETECTION OF SUSPECTED REGIONS IN CANCER
CN117085166A (zh) * 2023-08-24 2023-11-21 首都医科大学附属北京同仁医院 一种钽-海藻酸钙凝血酶微球及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4392040A (en) * 1981-01-09 1983-07-05 Rand Robert W Induction heating apparatus for use in causing necrosis of neoplasm
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
EP1819277A4 (en) * 2004-11-12 2010-05-05 Ltd Kpe NANOTE PARTICLE-MEDIATED ULTRASOUND THERAPY AND DIAGNOSTIC IMAGE DISPLAY
US9387036B2 (en) * 2007-05-14 2016-07-12 Pyrexar Medical Inc. Apparatus and method for selectively heating a deposit in fatty tissue in a body
US20100034735A1 (en) * 2008-08-06 2010-02-11 Jie Chen Targeted nanoparticles for cancer diagnosis and treatment

Also Published As

Publication number Publication date
JP2014528000A (ja) 2014-10-23
WO2013049600A1 (en) 2013-04-04
US20140228840A1 (en) 2014-08-14
WO2013049600A8 (en) 2014-08-07
CN104066450A (zh) 2014-09-24
EP2760472A1 (en) 2014-08-06

Similar Documents

Publication Publication Date Title
BR112013018352A2 (pt) composição de minociclina tópica e método
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
GT201400043A (es) Imidazopiridazinas sustituidas con amino
PE20131493A1 (es) Amidas aminoindanes con una alta actividad fungicida y sus composiciones fitosanitarias
CL2012002189A1 (es) Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos.
BR112015000041A2 (pt) micropartícula, método para a obtenção das micropartículas definidas, composição, produto alimentar, farmacêutico, cosmecêutico ou nutracêutico e uso de uma micropartícula
CL2014000759A1 (es) Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor que comprende al menos un ácido graso poliinsaturado de cadena larga (lc-pufa), al menos un probiótico y una mezcla de oligosacáridos; uso de la composición.
BR112012023014A2 (pt) composições fluidas detergentes que compreendem um gelificante de diamido e processos para produção das mesmas
BR112014002757A2 (pt) encapsulados
BR112015003742A2 (pt) sistema de montagem de componente de descarga
CL2015000289A1 (es) Compuesto citostatico derivado de niclosamida y compuesto alquilante derivado de 2,3,4,6,8-pentazabiciclo[4.3.0]nona-2,7-trieno; composicion farmaceutica que los comprende; y metodo para determinar si el tratamiento para un paciente con un tumor solido es adecuado.
AR125920A2 (es) Composiciones que comprenden vortioxetina y donepezil
CL2013003349A1 (es) Composicion que comprende una combinacion sinergica de un fungicida polienico y por lo menos un lipopeptido; y metodo para controlar patogenos fungicos.
BR112014031787A2 (pt) composição, métodos de substituição e para produção de refrigeração e equipamento de refrigeração.
CR20120357A (es) Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina
WO2015069697A3 (en) Combination therapy
BR112012019351A2 (pt) composição de combinação, que inclui como ingredientes ativos l-carnitina ou propionil l-carnitina, para a prevenção ou tratamento de insuficiência venosa crônica.
BR112013008324A2 (pt) composições para controlar os psilídeos trioza erytreae e disphorina citri, vetores de bastérias do gênero candidatus liberibacter, que causam a doença mais grave conhecida de citrus, a saber, huanglongbing (hlb)
CO6731092A2 (es) Nueva forma de administración de inhibidor de encefalinasa
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
BR112012029606A2 (pt) formulação, método para a fabricação de uma fomulação, método de tratamento de uma planta e uso de uma formulação
CL2013002034A1 (es) Composicion que comprende al menos un analogo de prostaciclina; su uso para tratar una enfermedad de la medula osea; y metodo para mejorar el injerto de celulas madre hematopoyeticas.
BR112013019394A2 (pt) uso de um agente
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]